QA-Bio
Private Company
Total funding raised: $3.2M
Overview
QA-Bio is a privately-held, commercial-stage company based in San Diego that supplies essential analytical tools for glycan characterization, a critical step in biopharmaceutical quality control. The company has established a global customer base, with its kits integrated into regulatory-approved manufacturing processes for biologics. Operating in the Diagnostics and Biologics sectors, QA-Bio generates revenue through the sale of its specialized reagent kits and related products to biopharma companies. Its value proposition centers on providing reliable, standardized tools that ensure accuracy and reproducibility in complex glycan analysis.
Technology Platform
Portfolio of optimized enzymatic and chemical reagent kits for glycan release, labeling, cleanup, and analysis, designed for accuracy and reproducibility in biopharmaceutical QC.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
QA-Bio competes in the niche glycan analysis reagent segment against the relevant divisions of large, diversified life science tools companies like Agilent, Thermo Fisher Scientific, and Merck KGaA. Its competitive advantage is deep specialization, proven use in regulatory submissions, and a focused product portfolio optimized for performance and ease-of-use.